Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
36th week of 2016 patent applcation highlights part 8
Patent application number
Title
Published
20160256464
ORALLY DISINTEGRATING TABLET COMPOSITIONS OF LAMOTRIGINE
2016-09-08
20160256465
FORMULATIONS OF VILOXAZINE
2016-09-08
20160256466
PI3K INHIBITOR FOR TREATMENT OF RESPIRATORY DISEASE
2016-09-08
20160256467
ANTI-PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (ANTI-PCSK9) COMPOUNDS AND METHODS OF USING THE SAME IN THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES
2016-09-08
20160256468
METHODS OF TREATING CANCER USING 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,- 6-DIONE
2016-09-08
20160256469
TRICYCLIC SULFONAMIDE COMPOUNDS AND METHODS OF MAKING AND USING SAME
2016-09-08
20160256470
AQUEOUS COMPOSITION
2016-09-08
20160256471
METHOD FOR TREATING NEUROCOGNITIVE DYSFUNCTION
2016-09-08
20160256472
COMPOSITIONS AND METHODS OF ADMINISTERING SAME
2016-09-08
20160256473
Oromucosal Liquid Estradiol Compositions
2016-09-08
20160256474
TOPICAL SPRAY COMPOSITION OF HALOBETASOL
2016-09-08
20160256475
METHODS OF TREATMENT OF DISEASES
2016-09-08
20160256476
NOVEL PARASITE THERAPY
2016-09-08
20160256477
COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC LIVER DISEASE OR INSULIN RESISTANCE COMPRISING GINSENOSIDE F2
2016-09-08
20160256478
METHODS OF TREATMENT
2016-09-08
20160256479
NUTRITIONAL FORMULATIONS USING HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION
2016-09-08
20160256480
THERAPEUTIC COMPOSITION FOR WOUND HEALING
2016-09-08
20160256481
USE OF WATER SOLUBLE PLATINUM COMPLEX IN PREPARING DRUGS FOR PREVENTION AND TREATMENT OF CANCERS
2016-09-08
20160256482
PHARMACEUTICAL COMPOSITION FOR IMPROVING WOUND HEALING OR PROPHYLACTICALLY PREVENTING OR INHIBITING SCAR FORMATION
2016-09-08
20160256483
POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
2016-09-08
20160256484
Topical Compositions and Methods of Using the Same
2016-09-08
20160256485
TREATMENT OR PREVENTION OF PULMONARY CONDITIONS WITH CARBON MONOXIDE
2016-09-08
20160256486
USE OF FERRIC CITRATE IN THE TREATMENT OF AND THE REDUCTION OF MORTALITY AND MORBIDITY RELATED TO ADVERSE CARDIAC EVENTS IN CHRONIC KIDNEY DISEASE PATIENTS
2016-09-08
20160256487
POLYCLONAL GAMMA DELTA T CELLS FOR IMMUNOTHERAPY
2016-09-08
20160256488
Reducing Immune Tolerance Induced by PD-L1
2016-09-08
20160256489
Allograft tolerance induction
2016-09-08
20160256490
ACELLULAR BIOLOGIC COMPOSITION AND METHOD OF MANUFACTURE
2016-09-08
20160256491
BIOLOGIC COMPOSITION AND METHOD OF MANUFACTURE
2016-09-08
20160256492
Method
2016-09-08
20160256493
BIOLOGIC COMPOSITION AND METHOD OF MANUFACTURE
2016-09-08
20160256494
METHOD FOR COMBINED CONDITIONING AND CHEMOSELECTION IN A SINGLE CYCLE
2016-09-08
20160256495
METHOD FOR PREPARATION OF INDUCED DOPAMINERGIC PROGENITORS USING DIRECT REPROGRAMMING
2016-09-08
20160256496
PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF ORTHOPEDIC PATHOLOGIES
2016-09-08
20160256497
METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
2016-09-08
20160256499
METHODS AND COMPOSITIONS FOR PRODUCING HEPATOCYTE-LIKE CELLS
2016-09-08
20160256500
METHODS OF TREATING CHRONIC WOUNDS WITH AMNIOTIC FLUID HAVING ELEVATED LEVELS OF TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES
2016-09-08
20160256501
A THERAPEUTIC AGENT DELIVERY SYSTEM AND METHOD FOR ARTERIES
2016-09-08
20160256502
Modulation of Splenocytes in Cell Therapy for Traumatic Brain Injury
2016-09-08
20160256503
ISOLATION OF OMEGA-7 FATTY ACID ETHYL ESTERS FROM NATURAL OILS
2016-09-08
20160256504
ANTIHYPERTENSIVE COMPOSITION CONTAINING SHIITAKE MUSHROOM [LENTINUS EDODES] MYCELIUM CULTURE AND NATTO BACTERIA [BACILLUS SUBTILIS NATTO] CULTURE
2016-09-08
20160256505
FATTY ACID COMPOSITION AND PLANT EXTRACT AND PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF
2016-09-08
20160256506
METHODS AND COMPOSITIONS FOR ENHANCING OR MAINTAINING FERTILITY
2016-09-08
20160256507
ANTI-INFLAMMATORY USE OF LIQUID PHYTOCOMPLEXES FROM OLIVE
2016-09-08
20160256508
COMPOSITIONS CONTAINING NITRO FATTY ACIDS
2016-09-08
20160256509
Vasodilator Formulation and Method of Use
2016-09-08
20160256510
PALIURUS RAMOSISSIMUS (LOUR.) POIR EXTRACT AND PREPARATION METHOD AND USES THEREOF
2016-09-08
20160256511
COMPOSITIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF CIRCADIAN PROTEIN RELATED CONDITIONS
2016-09-08
20160256512
METHOD FOR THE MANAGEMENT OF CANCER AND CANCER TREATMENT-RELATED COMORBIDITIES
2016-09-08
20160256513
SYNERGIZED TURMERIC
2016-09-08
20160256514
METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING
2016-09-08
20160256515
COMPOSITIONS AND METHODS FOR PREDICTION AND TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTIONS
2016-09-08
20160256516
Phosphorylcholine Conjugates and Uses Thereof
2016-09-08
20160256518
PEPTIDES FOR INHIBITING ANGIOGENESIS
2016-09-08
20160256519
THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE
2016-09-08
20160256520
TOPICAL FORMULATIONS AND USES THEREOF
2016-09-08
20160256521
TOPICAL FORMULATIONS AND USES THEREOF
2016-09-08
20160256522
METHOD FOR ENHANCING WOUND HEALING
2016-09-08
20160256523
SYNDECAN PEPTIDES AND POLYPEPTIDES AS INHIBITORS OF VEGFR2 AND VLA-4
2016-09-08
20160256524
Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury
2016-09-08
20160256525
MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME
2016-09-08
20160256526
METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS WITH FOLLISTATIN POLYPEPTIDES
2016-09-08
20160256527
TNFRSF-BINDING AGENTS AND USES THEREOF
2016-09-08
20160256528
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING RADIATION- OR CHEMOTHERAPY-INDUCED PULMONARY DYSFUNCTION
2016-09-08
20160256529
COMBINATION THERAPY
2016-09-08
20160256530
METHODS AND COMPOSITIONS FOR THE IDENTIFICATION AND TREATMENT OF INDIVIDUALS HAVING OR LIKELY TO DEVELOP SHORT STATURE
2016-09-08
20160256531
TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING BOTULINUM TOXIN A
2016-09-08
20160256532
Albumin-Free Botulinum Toxin Formulations
2016-09-08
20160256533
SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION
2016-09-08
20160256534
METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS
2016-09-08
20160256535
HEXAPEPTIDE AND USES THEREOF
2016-09-08
20160256536
PRRSV GP5 BASED COMPOSITIONS AND METHODS
2016-09-08
20160256537
INFLUENZA VACCINE
2016-09-08
20160256538
USE OF LISTERIA VACCINE VECTORS TO REVERSE VACCINE UNRESPONSIVENESS IN PARASITICALLY INFECTED INDIVIDUALS
2016-09-08
20160256539
HIV-1 ENV DNA Vaccine Plus Protein Boost Delivered by EP Expands B- and T-Cell Response and Neutralizing
2016-09-08
20160256540
Methods And Compositions For Treatment Of S. Equi Infection
2016-09-08
20160256541
Cationic Oil-In-Water Emulsions
2016-09-08
20160256542
Use of a Lipopeptide or Lipoprotein as an Adjuvant in Therapeutic or Prophylactic Vaccinations
2016-09-08
20160256543
IMMUNOPOTENTIATOR
2016-09-08
20160256544
ADJUVANTED VACCINES FOR IN OVO AVIAN VACCINATION
2016-09-08
20160256545
Stable Aqueous Formulations of Adalimumab
2016-09-08
20160256546
Stable Aqueous Formulations of Adalimumab
2016-09-08
20160256547
Stable Aqueous Formulations of Adalimumab
2016-09-08
20160256548
ENHANCED PLASMONIC NANOPARTICLES FOR CANCER THERAPY AND DIAGNOSTICS
2016-09-08
20160256549
LIGHT-GUIDING HYDROGEL DEVICES FOR CELL-BASED SENSING OF AN INTERACTOIN WITH AMBIENT
2016-09-08
20160256550
FUNCTIONAL, CROSS-LINKED NANOSTRUCTURES FOR TANDEM OPTICAL IMAGING AND THERAPY
2016-09-08
20160256551
ADHD/OCD Treatment
2016-09-08
20160256552
TRANSDERMAL COLLOIDAL SOLUTION AGENT
2016-09-08
20160256553
Variants of C-Type Natriuretic Peptide
2016-09-08
20160256554
REDUCED FOAMING VACCINE COMPOSITIONS
2016-09-08
20160256555
STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS
2016-09-08
20160256556
OIL/FAT COMPOSITION CONTAINING POLYUNSATURATED FATTY ACID
2016-09-08
20160256557
INJECTABLE PHARMACEUTICAL COMPOSITIONS OF AN ANTHRACENEDIONE DERIVATIVE WITH ANTI-TUMORAL ACTIVITY
2016-09-08
20160256558
GABA CONJUGATES AND METHODS OF USE THEREOF
2016-09-08
20160256559
STERICALLY STABILIZED CATIONIC NANOCARRIER, KITS AND METHOD OF USE
2016-09-08
20160256560
Environmentally Sensitive Compositions
2016-09-08
20160256561
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
2016-09-08
20160256562
ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER
2016-09-08
20160256563
ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 161P2F10B PROTEINS
2016-09-08
20160256564
PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES
2016-09-08
20160256565
Composite bioabsorbable barrier membranes with sustained dual drug delivery for tissue engineering and guided tissue regeneration
2016-09-08
